Exane Derivatives’s Array Technologies ARRY Stock Holding History

Exane Derivatives’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,928	Closed	-$61.1K	–	1049
2021 Q2	$61.1K	Buy	+3,928	New	+$82.8K	0.01%	622

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Exane Derivatives's ARRY Position: Q3 2021 in Review

Exane Derivatives sold out of Array Technologies (ARRY) in Q3 2021, closing a stake of 3,928 shares — an estimated $61.1K sold.

Exane Derivatives first reported a position in ARRY in Q2 2021 and held it in 1 quarter. The position peaked at $61.1K in Q2 2021. 188 funds tracked by Wall St. Rank hold ARRY as of Q3 2021.

Exane Derivatives reported no remaining Array Technologies position as of Q3 2021 after selling out during the quarter.
Exane Derivatives sold 3,928 Array Technologies shares in Q3 2021, an estimated $61.1K.
Exane Derivatives first reported a position in Array Technologies in Q2 2021 and held it in 1 quarter.
Exane Derivatives's Array Technologies position peaked at $61.1K in Q2 2021.
188 funds tracked by Wall St. Rank held Array Technologies as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.